Related references
Note: Only part of the references are listed.A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Long-Term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis
Sumeyye Samur et al.
HEPATOLOGY (2017)
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
J. K. Dyson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection
Christopher L. Bowlus
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2016)
Health related quality of life in people with advanced chronic liver disease
James G. Orr et al.
JOURNAL OF HEPATOLOGY (2014)
THE FIRST PRIMARY BILIARY CIRRHOSIS (PBC) PHASE 3 TRIAL IN TWO DECADES - AN INTERNATIONAL STUDY OF THE FXR AGONIST OBETICHOLIC ACID IN PBC PATIENTS
F. Nevens et al.
JOURNAL OF HEPATOLOGY (2014)
Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid
Marco Carbone et al.
GASTROENTEROLOGY (2013)
Impact of Primary Biliary Cirrhosis on Perceived Quality of Life: The UK-PBC National Study
George F. Mells et al.
HEPATOLOGY (2013)
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Kirsten Boonstra et al.
JOURNAL OF HEPATOLOGY (2012)
Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
Ben van Hout et al.
VALUE IN HEALTH (2012)
Some methodological issues with the analysis of preference-based EQ-5D index score
Liang Li et al.
HEALTH SERVICES AND OUTCOMES RESEARCH METHODOLOGY (2009)
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2008)
Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure
JL Newton et al.
JOURNAL OF HEPATOLOGY (2006)
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis
A Jacoby et al.
GUT (2005)
Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups
L Longworth et al.
LIVER TRANSPLANTATION (2003)
The true impact of fatigue in primary biliary cirrhosis: A population study
J Goldblatt et al.
GASTROENTEROLOGY (2002)
Estimating log models: to transform or not to transform?
WG Manning et al.
JOURNAL OF HEALTH ECONOMICS (2001)
An exploratory population-based case-control study of primary biliary cirrhosis
D Howel et al.
HEPATOLOGY (2000)
Share Paper
